Lewis, K. D., Peris, K., Sekulic, A., Stratigos, A. J., Dunn, L., Eroglu, Z., Chang, A. L. S., Migden, M. R., Yoo, S.-Y., Mohan, K., Coates, E., Okoye, E., Baurain, J.-F., Bechter, O., Hauscild, A., Butler, M. O., Hernandez-Aya, L., Licitra, L., Neves, R. I., Ruiz, E. S., Seebach, F., Lowy, I., Goncalves, P., & Fury, M. G. (2023). Primary analysis of Phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma who progressed on or were intolerant to hedgehog inhibitors. SKIN The Journal of Cutaneous Medicine, 7(2), s177. https://doi.org/10.25251/skin.7.supp.177